Display options
Share it on

Blood Cancer J. 2013 Nov 15;3:e159. doi: 10.1038/bcj.2013.57.

Association between decreasing trend in the mortality of adult T-cell leukemia/lymphoma and allogeneic hematopoietic stem cell transplants in Japan: analysis of Japanese vital statistics and Japan Society for Hematopoietic Cell Transplantation (JSHCT).

Blood cancer journal

D Chihara, H Ito, T Matsuda, K Katanoda, A Shibata, S Taniguchi, A Utsunomiya, T Sobue, K Matsuo

Affiliations

  1. Division of Epidemiology and Prevention, Aichi Cancer Center Research Institute, Nagoya, Japan.

PMID: 24241399 PMCID: PMC3880440 DOI: 10.1038/bcj.2013.57

Abstract

Adult T-cell leukemia/lymphoma (ATLL) is a peripheral T-cell neoplasm with a very poor outcome. However, several studies have shown a progress in the treatment. To evaluate the effect of the progress in the treatment of ATLL in a whole patient population, we used vital statistics data and estimated age-adjusted mortality and trends in the mortality from 1995 to 2009. Since allogeneic hematopoietic stem-cell transplantation (allo-HSCT) has been introduced as a modality with curative potential during study period, we also evaluated the association of the annual number of allo-HSCT and the trend of the mortality of ATLL. Endemic (Kyushu) and non-endemic areas (others) were evaluated separately. Significance in the trend of mortality was evaluated by joinpoint regression analysis. During the study period, a total of 14 932 patients died of ATLL in Japan, and mortality decreased significantly in both areas (annual percent change (95% confidence interval (CI)): Kyushu, -3.1% (-4.3, -1.9); others, -3.4% (-5.3, -1.5)). This decreasing trend in mortality seems to be associated with an increase in the number of allo-HSCTs (Kyushu, R-squared=0.70, P=0.003; and others, R-squared=0.55, P=0.058). This study reveals that the mortality of ATLL is now significantly decreasing in Japan and this decreasing trend might be associated with allo-HSCT.

References

  1. J Clin Oncol. 2007 Dec 1;25(34):5458-64 - PubMed
  2. J Clin Oncol. 2012 Mar 10;30(8):837-42 - PubMed
  3. J Clin Oncol. 2010 Mar 20;28(9):1591-8 - PubMed
  4. Blood. 2012 Aug 23;120(8):1734-41 - PubMed
  5. Stat Med. 2000 Feb 15;19(3):335-51 - PubMed
  6. Blood. 2005 May 15;105(10):4143-5 - PubMed
  7. Biol Blood Marrow Transplant. 2007 Jan;13(1):90-9 - PubMed
  8. Cancer Sci. 2012 Oct;103(10):1857-60 - PubMed
  9. J Clin Oncol. 2009 Jan 20;27(3):453-9 - PubMed
  10. J Med Virol. 2012 Feb;84(2):327-35 - PubMed
  11. Jpn J Clin Oncol. 2013 May;43(5):492-507 - PubMed
  12. Br J Haematol. 2001 May;113(2):375-82 - PubMed
  13. Bone Marrow Transplant. 2001 Jan;27(1):15-20 - PubMed
  14. Int J Hematol. 2003 Feb;77(2):164-70 - PubMed
  15. Blood. 2010 Aug 26;116(8):1369-76 - PubMed
  16. Br J Haematol. 1991 Nov;79(3):428-37 - PubMed

Publication Types